Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome

---

Atıf İçin Kopyala

BAKIRCI E. M., ÜNVER E., DEĞİRMENCİ H., Kivanc T., Gunay M., HAMUR H., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.43, sa.4, ss.333-339, 2015 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 43 Sayı: 4
• Basım Tarihi: 2015
• Doi Numarası: 10.5543/tkda.2015.56805
• Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.333-339
• Erzincan Binali Yıldırım Üniversitesi Adresli: Evet

Özet

Objective: The inflammatory process plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnea syndrome (OSAS). YKL-40/chitinase 3-like protein 1 is a novel biomarker of systemic inflammation. This study aimed to investigate whether carotid intima-media thickness (CIMT), a useful marker for early atherosclerosis, is associated with serum YKL-40/chitinase 3-like protein 1 levels in patients with normotensive and nondiabetic OSAS.